����ֱ����Ƶ

“The first of its kind in Keneba” according to the feedback received from people who came from all over the surrounding villages in West Kiang to find out more about MRCG

The Development of Electronic Medical Records System (EMRS) for MRC Unit The Gambia Clinical Services Department (CSD) project is a major project milestone which serves as a tool to aid physicians

Originally from Nigeria, trained paediatrician and  clinical trial coordinator, Dr Idoko has worked at MRC Unit The Gambia since June 2010 (following a 1-year stint between Jul 2007 and Jul 2008).

Numerous risk factors can impact on a child’s brain development in the early years of life and most critically in the first 24 months.

Although malaria still contributes significantly to both morbidity and mortality in sub-Saharan Africa, the last decade has seen major progress in the fight against malaria as the burden has substa

The European Medicines Agency (EMA) have approved a new multi-dose preparation of Prevenar 13®, sponsored by biopharmaceutical company Pfizer, based on a study conducted by MRC Unit The Gambia.The

The Quality Journey at MRCG started with the Clinical Trials Support Office (CTSO) in 2006 which lead to the establishment of the Quality Department in 2008.In 2006, the Clinical Trial Support Offi

The management team of MRC Unit The Gambia (MRCG) has introduced a pioneering employee health promotion programme for all staff.

The Periodic Health Maintenance and Examination organised by the Clinical Services Department, as an effective way to identify hidden risks of diseases and to help staff understand their individual

Sarah Dufie Sarpong is the Head of Health, Safety and Environment (HSE) at MRC Unit The Gambia (MRCG).

Badou Gaye, the Head of Information Technology (IT) is a Gambian who plays a pivotal leadership role in strengthening the quality of IT management systems and improve coordination of IT related act

The World Health Organisation has pre-qualified Pfizer’s new four-dose, multi-dose vial (MDV) presentation of Prevenar 13®*, based on the results of a study conducted by MRC Unit The Gambia (MRCG)